Meeting USP Guidelines for Elemental Impurity Analysis with X-ray Fluorescence Spectrometry

March 15, 2016
Andrew Fussell

Pharmaceutical Technology, Pharmaceutical Technology-03-15-2016, Volume 2016 eBook, Issue 1
Page Number: s40-s45

The author discusses how x-ray spectrometry can be an effective way to measure these impurities and meet regulatory guidelines.

In sufficiently high concentrations, elemental impurities, typically from catalyst residue, can pose safety risks.  The author discusses how x-ray spectrometry can be an effective way to measure these impurities and meet regulatory guidelines.

from Pharmaceutical Technology’s 2016 Solid Dosage Drug Development and Manufacturing eBook.

View other articles in the